Cargando…

Nlrp3 Inflammasome Activation in Type 2 Diabetes: Is It Clinically Relevant?

Detalles Bibliográficos
Autor principal:	Dixit, Vishwa Deep
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Diabetes Association 2013
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3526045/ https://www.ncbi.nlm.nih.gov/pubmed/23258906 http://dx.doi.org/10.2337/db12-1115

Ejemplares similares

AGING INDUCES NLRP3 INFLAMMASOME DEPENDENT ADIPOSE B CELL EXPANSION TO IMPAIR METABOLIC HOMEOSTASIS
por: Camell, Christina, et al.
Publicado: (2019)

Mechanisms of disease: inflammasome activation and the development of type 2 diabetes
por: Grant, Ryan W., et al.
Publicado: (2013)

Reduction of SPARC protects mice against NLRP3 inflammasome activation and obesity
por: Ryu, Seungjin, et al.
Publicado: (2023)

The NALP3/NLRP3 Inflammasome Instigates Obesity-Induced Autoinflammation and Insulin Resistance
por: Vandanmagsar, Bolormaa, et al.
Publicado: (2011)

Adipose Tissue Macrophages Are Innate to the Immunological Awareness of Adipose Tissue
por: Dixit, Vishwa Deep
Publicado: (2013)

Growth Hormone Receptor Deficiency Protects against Age-Related NLRP3 Inflammasome Activation and Immune Senescence
por: Spadaro, Olga, et al.
Publicado: (2016)

On the Need for Human Studies of PM Exposure Activation of the NLRP3 Inflammasome
por: Brugge, Doug, et al.
Publicado: (2023)

Upregulated NLRP3 Inflammasome Activation in Patients With Type 2 Diabetes
por: Lee, Hye-Mi, et al.
Publicado: (2013)

Smoking‐aggravated oral candidiasis: Nrf2 pathway dampens NLRP3 inflammasome
por: Osman, Marwan, et al.
Publicado: (2021)

The NLRP3 Inflammasome: Relevance in Solid Organ Transplantation
por: Burke, Ryan M., et al.
Publicado: (2021)

Pharmacoepigenetics in type 2 diabetes: is it clinically relevant?
por: Ling, Charlotte
Publicado: (2022)

Ketone body β-hydroxybutyrate blocks the NLRP3 inflammasome-mediated inflammatory disease
por: Youm, Yun-Hee, et al.
Publicado: (2015)

Relevance of the NLRP3 Inflammasome in the Pathogenesis of Chronic Liver Disease
por: Wu, Xiaoqin, et al.
Publicado: (2017)

Hypoxia-inducible factor-1 α and RIP3 triggers NLRP3 inflammasome in ischemic stroke
por: Jiang, Qian, et al.
Publicado: (2018)

Role of NLRP3 inflammasome in diabetes and COVID-19 role of NLRP3 inflammasome in the pathogenesis and treatment of COVID-19 and diabetes NLRP3 inflammasome in diabetes and COVID-19 intervention
por: Zhang, Jiayu, et al.
Publicado: (2023)

NLRP3 Inflammasome Polymorphism and Macrovascular Complications in Type 2 Diabetes Patients
por: Klen, Jasna, et al.
Publicado: (2015)

NLRP3 Inflammasome at the Interface of Inflammation, Endothelial Dysfunction, and Type 2 Diabetes
por: Gora, Ilona M., et al.
Publicado: (2021)

The Good, the Bad, and NLRP3-characterizing Novel Roles for the Inflammasome in Adipose–Tissue Biology and Burn Trauma
por: Asarian, Lori
Publicado: (2021)

Characterization of NLRP3 Inflammasome Activation in the Onset of Diabetic Retinopathy
por: Kuo, Charisse Y-J., et al.
Publicado: (2022)

Modulatory Mechanisms of the NLRP3 Inflammasomes in Diabetes
por: Ding, Sujuan, et al.
Publicado: (2019)

NLRP3 inflammasome activation is involved in manganese-induced immunotoxicity: Mn activates macrophage NLRP3 inflammasome
por: Ji, Jing, et al.
Publicado: (2021)

Research Progress of Mitochondrial Mechanism in NLRP3 Inflammasome Activation and Exercise Regulation of NLRP3 Inflammasome
por: Zhang, Tan, et al.
Publicado: (2021)

The NLRP3 and NLRP1 inflammasomes are activated in Alzheimer’s disease
por: Saresella, Marina, et al.
Publicado: (2016)

NLRP3 Inflammasome and Pyroptosis in Liver Pathophysiology: The Emerging Relevance of Nrf2 Inducers
por: Hurtado-Navarro, Laura, et al.
Publicado: (2022)

The Role of H(2)S Regulating NLRP3 Inflammasome in Diabetes
por: Zhao, Huijie, et al.
Publicado: (2022)

Relevance of NLRP3 Inflammasome-Related Pathways in the Pathology of Diabetic Wound Healing and Possible Therapeutic Targets
por: Ding, Youjun, et al.
Publicado: (2022)

Mitochondrial DNA Activates the NLRP3 Inflammasome and Predisposes to Type 1 Diabetes in Murine Model
por: Carlos, Daniela, et al.
Publicado: (2017)

The mechanisms of NLRP3 inflammasome/pyroptosis activation and their role in diabetic retinopathy
por: Zheng, Xiaoqin, et al.
Publicado: (2023)

NLRP3 licenses NLRP11 for inflammasome activation in human macrophages
por: Gangopadhyay, Anu, et al.
Publicado: (2022)

NLRP3 Inflammasome in Diabetic Cardiomyopathy and Exercise Intervention
por: Sun, Yi, et al.
Publicado: (2021)

The Role of NLRP3 Inflammasome Signaling on Arrhythmias in Diabetes
por: Zhang, Lei, et al.
Publicado: (2022)

NLRP3 Inflammasome Activation by Paracoccidioides brasiliensis
por: Tavares, Aldo Henrique, et al.
Publicado: (2013)

Vimentin regulates activation of the NLRP3 inflammasome
por: dos Santos, Gimena, et al.
Publicado: (2015)

Alum Activates the Bovine NLRP3 Inflammasome
por: Harte, Ciaran, et al.
Publicado: (2017)

Dicer regulates activation of the NLRP3 inflammasome
por: Ojcius, David M., et al.
Publicado: (2019)

NLRP3 inflammasome activation in response to metals
por: Huang, Wanyi, et al.
Publicado: (2023)

Inhibiting the NLRP3 Inflammasome
por: El-Sharkawy, Lina Y., et al.
Publicado: (2020)

NLRP3 Inflammasome and Mineralocorticoid Receptors Are Associated with Vascular Dysfunction in Type 2 Diabetes Mellitus
por: Ferreira, Nathanne Santos, et al.
Publicado: (2019)

Expression and Mechanism of TXNIP/NLRP3 Inflammasome in Sciatic Nerve of Type 2 Diabetic Rats
por: Han, Le, et al.
Publicado: (2022)

Neuropsychological decrements in midlife type-2 diabetes are not associated with peripheral NLRP3 inflammasome responsiveness
por: Dyer, Adam H., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_qkf66v50lcajmu6s0hv594vqkv